Please wait while we load the requested 10-K report or click the link below:
USANA Health Sciences Announces Fourth Quarter and Full-Year 2010 Financial Results
- 2010 marks the 8th consecutive year of record sales ($517.6 million)
- Net sales increase to a quarterly record of $137.5 million
- Earnings per share increase to $2.86 for the year and $0.75 for the quarter
- Guidance provided for 2011
SALT LAKE CITY--(BUSINESS WIRE)--February 8, 2011--USANA Health Sciences, Inc. (NASDAQ: USNA) today announced financial results for its fiscal fourth quarter and full-year ended January 1, 2011.
Net sales in the fourth quarter of 2010 increased by 17.8% to a record $137.5 million, compared with $116.8 million in the fourth quarter of the prior year. This growth was due to higher product sales and an increased number of active associates, primarily driven by the Asia Pacific region. Sales from the newly acquired BabyCare operation in China added $4.1 million and favorable changes in currency exchange rates added $3.6 million in sales.
Net earnings in the fourth quarter increased by 21.4% to $12.4 million, or $0.75 per share, compared with $0.66 per share, in the fourth quarter of the prior year. This increase resulted from improved gross profit margins and a lower effective tax rate. Earnings per share gains, however, were partially offset by a higher number of diluted shares outstanding and additional operating costs related to BabyCare operations in China.
The following information was filed by Usana Health Sciences Inc (USNA) on Tuesday, February 8, 2011 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one year to another to evaluate Usana Health Sciences Inc's financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were
removed , and by Usana Health Sciences Inc.